Similar articles

• [A double-blind crossover trial of alizapride versus placebo regarding effectiveness against nausea and emesis induced by cancer chemotherapeutic agents (author's transl)].

  Pommatau E. Pommatau E. Sem Hop. 1982 Feb 11;58(6):363-6. Sem Hop. 1982. PMID: 6280304 French. No abstract available.
• [Evaluation of a new antiemetic, alizapride, in cancerology (author's transl)].

  Cupissol D, Favier F, Favier C, Serrou B. Cupissol D, et al. Sem Hop. 1982 Jun 3;58(22):1370-3. Sem Hop. 1982. PMID: 6287597 French.
• Chemotherapy-induced nausea and vomiting with special emphasis on metopimazine.

  Herrstedt J. Herrstedt J. Dan Med Bull. 1998 Sep;45(4):412-22. Dan Med Bull. 1998. PMID: 9777292 Review. No abstract available.
• [A comparative study of alizapride and metopimazine (author's transl)].

  Casanova P, Girard D. Casanova P, et al. Sem Hop. 1982 Feb 11;58(6):345-8. Sem Hop. 1982. PMID: 6280300 French. No abstract available.
• Preventing chemotherapy-induced nausea and vomiting: an update and a review of emesis.

  Ettinger DS. Ettinger DS. Semin Oncol. 1995 Aug;22(4 Suppl 10):6-18. Semin Oncol. 1995. PMID: 7570053 Review. No abstract available.